| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |